Smad7 differentially regulates transforming growth factor beta-mediated signaling pathways.
about
Promoting bone morphogenetic protein signaling through negative regulation of inhibitory SmadsCHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradationSmad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formationJab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradationInteraction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosisTGF-β/Smad signaling in renal fibrosisSmads as therapeutic targets for chronic kidney diseasePlatelet-derived growth factor requires epidermal growth factor receptor to activate p21-activated kinase family kinasesRole of the TGF-β/BMP-7/Smad pathways in renal diseasesDecreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heartA simple method allowing DIC imaging in conjunction with confocal microscopy.The Chinese medicine, Jianpi Huayu Decoction, inhibits the epithelial mesenchymal transition via the regulation of the Smad3/Smad7 cascade.Loss of transforming growth factor counteraction on interleukin 1 mediated effects in cartilage of old miceThe story so far: Molecular regulation of the heme oxygenase-1 gene in renal injury.Establishment of an artificial beta-cell line expressing insulin under the control of doxycycline.TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancers.Role of Transforming Growth Factor-β1 and Smads Signaling Pathway in Intrauterine Adhesion.TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.Transforming growth factor beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene.Smad7 induces G0/G1 cell cycle arrest in mesenchymal cells by inhibiting the expression of G1 cyclins.Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein.Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling.Bone morphogenetic protein signaling modulates myocardin transactivation of cardiac genes.Interferon-gamma inhibits transforming growth factor-beta production in human airway epithelial cells by targeting Smads.Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation.Andrographolide Ameliorates Liver Fibrosis in Mice: Involvement of TLR4/NF-κB and TGF-β1/Smad2 Signaling Pathways.Ras enhances TGF-β signaling by decreasing cellular protein levels of its type II receptor negative regulator SPSB1.Anti-fibrotic impact of Carvedilol in a CCl-4 model of liver fibrosis via serum microRNA-200a/SMAD7 enhancement to bridle TGF-β1/EMT track
P2860
Q24291512-2F18DF77-6646-47EB-83D5-F87C03BF2233Q24298589-C9AD549A-52C9-4D27-876B-8BE2FD59FC08Q24302554-D81FFC2F-80D0-4349-9A4C-B845909FF458Q24313377-57ACC375-C7DC-4004-B816-851D99D4C3A6Q24556984-3A5A0A2A-57AB-402B-B343-36C810DB8BA3Q26851198-85E50D41-FD2B-4EA4-8A54-2D1D1B3CE2B0Q26865998-B17FE921-B2FE-423D-B5AE-019E393D2227Q28189335-0B43ECCF-6D1D-475A-8C82-43B149CEA0DCQ28278757-B948386A-AB8F-4C96-8ADA-FF0C788112D9Q28581449-BCF04733-6B6A-4C4D-ACC2-9763DB96ADF7Q33212191-A51CBC75-7E2E-47C3-BCF1-2F36EFD964C7Q33850210-D1CAEF61-CB45-479E-BB89-BE14A8B45D8CQ35551193-527FD47A-774C-4058-80AF-0600D72AD940Q35648481-937E849D-A81E-49CD-91FC-E6241B5E094FQ36316148-BB9DF2FF-77DF-488F-BC58-575E5E0898D4Q36560020-5D93C52D-DBA3-4479-AFF5-CB0DA318FFAAQ36655274-E956B3B5-D7D7-4090-9963-7C09A4C27D2DQ36737131-FD922DA1-FDBD-4BA9-941D-3AFAD1748F02Q37934555-2B9DFFA3-9CAD-4D5B-9595-92A6405E0142Q38868773-1B188E0A-F438-4D20-94A5-15F21310BEF9Q40265633-FD1E5698-77AA-4108-AB19-7984C9202A24Q40351576-90FA6278-23B2-421C-AFF1-00204D81DFF5Q40438629-EE549037-398A-4340-BB35-BAF7591ABA2EQ41890914-55C61EDC-210A-40E8-8001-2D268ACB3695Q42025588-F86C3E38-A5CD-4C79-AD19-ECDAE741A861Q42455495-DBB8E4FF-9189-4640-9A11-E4C06A252CD9Q42830492-8D64C7D8-1B52-406D-8684-33089A720970Q54981313-69BFCD95-A954-4AA4-ABC1-29BB875A6BBDQ55013837-74C8F9D3-F97C-45B1-855F-9981B806ADB3Q58698696-4144FB92-7525-485C-B16A-2880C282015E
P2860
Smad7 differentially regulates transforming growth factor beta-mediated signaling pathways.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Smad7 differentially regulates ...... a-mediated signaling pathways.
@en
type
label
Smad7 differentially regulates ...... a-mediated signaling pathways.
@en
prefLabel
Smad7 differentially regulates ...... a-mediated signaling pathways.
@en
P2093
P2860
P356
P1476
Smad7 differentially regulates ...... a-mediated signaling pathways.
@en
P2093
P2860
P304
32258-32264
P356
10.1074/JBC.274.45.32258
P407
P577
1999-11-01T00:00:00Z